FDA Advisory Panel Recommends Prevnar Vaccine

Boston (DbTechNo) – An advisory panel to the FDA have given their vote of confidence to a newer version of Prevnar, a Pfizer vaccine to combat diseases caused by pneumococcus bacteria.

This vaccine is very important as it protects children against pneumonia and meningitis, 2 very serious health conditions that can result in death.

The vaccine protects against up to 13 different types of streptococcus pneumoniae, which left untreated, can kill children.

“We’re very gratified to have achieved a positive recommendation,” Dr. Emilio Emini, Pfizer’s chief scientific officer for vaccine research, said in a statement.

The original version of Prevnar, only targets seven strains of bacterium, and was introduced onto the market back in 2000.

The FDA now have to decide whether or not to approve the vaccine and although their panel recommends it, they do not have to agree.

• Share
• Tweet
• "&title=""">